Influenza homepage

Fluzone Quadrivalent is FDA approved to treat influenza in children falling within the six to 35-month age .-Sanofi Pasteur.

The FDA has approved the 0.5mL dose of its influenza vaccine, Fluzone Quadrivalent, from Sanofi Pasteur, for treating children falling...

Added 3 months ago Drug news

FDA approves Xofluza to treat acute, uncomplicated influenza. Genentech/Roche

Genentech, a member of the Roche Group announced that the FDA has approved Xofluza (baloxavir marboxil) for the treatment of...

Added 3 months ago Drug news

CHMP recommends Flucelvax Tetra a quadrivalent cell-based influenza vaccine.-Seqirus/CSL

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended granting marketing authorization for...

Search all news articles for Influenza

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Chronic Obstructive Pulmonary Disease (COPD)

View highlights from recent congresses presented in new expert videos with leading physicians.

Allergic Rhinitis

Allergic rhinitis causes great strain on the workforce. Help to reduce sick days and improve productivity with appropriate treatment options.

Safety and immunogenicity of co-administered MF59-adjuvanted 2009 pandemic and plain 2009–10 seasonal influenza vaccines in rheumatoid arthritis patients on biologicals

Rheumatoid arthritis (RA) patients under immunosuppressive therapy are particularly susceptible to infections, mainly of the respiratory tract, thus vaccination may...

Added 4 years ago

A/H5N1 prepandemic influenza vaccine (Vepacel®): a guide to its use.

Vepacel® is a prepandemic influenza vaccine (whole virion, Vero cell-derived, inactivated) containing antigen of H5N1 strain A/Vietnam/1203/2004 and is approved...

Added 6 years ago

A/H5N1 prepandemic influenza vaccine (whole virion, vero cell-derived, inactivated) [Vepacel®].

The influenza A subtype H5N1 virus is a likely causative agent for the next human influenza pandemic. Pandemic influenza vaccine...

Added 6 years ago

Search all journal articles for Influenza

Study of S-033188 (Baloxavir Marboxil) Compared With Placebo or Oseltamivir in Patients With Influenza at High Risk of Influenza Complications (CAPSTONE 2)

The primary objective of this study is to evaluate the efficacy of a single, oral dose of Baloxavir Marboxil compared with placebo by measuring the time to improvement of influenza symptoms in patients with influenza...

Added 7 months ago

A Study of S-033188 (Baloxavir Marboxil) Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza (CAPSTONE 1)

The primary objective of this study is to evaluate the efficacy of a single, oral dose of Baloxavir Marboxil compared with placebo by measuring the time to alleviation of symptoms in patients with uncomplicated influenza virus infection.

Added 7 months ago

Search all clinical trials for Influenza

A

C

D

E

G

H

I

M

N

O

P

R

S

T

U

A

C

D

H

I

L

M

N

O

P

R

A

B

C

Learning Zones in English